`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www .uspto.gov
`
`APPLICATION NO.
`
`15/589,572
`
`ISSUE DATE
`
`11/14/2017
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`9816046
`
`AKBM-14409/US- l 4/CON
`
`6984
`
`7590
`72960
`Casimir Jones, S.C.
`2275 DEMING WAY, SUITE 310
`MIDDLETON, WI 53562
`
`10/25/2017
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(s) (Please see PAIR WEB site http://pair.uspto.gov for additional applicants):
`
`Inge Bruheim, Valda, NORWAY;
`AKER BIOMARINE ANTARCTIC AS, Stamsund, NORWAY;
`Snorre Tilseth, Bergen, NORWAY;
`Daniele Mancinelli, Orsta, NORWAY;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`RIMFROST EXHIBIT 1113 Page 0001
`
`IR103 (Rev. 10/09)
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`Sheet
`
`I
`
`4
`
`I
`
`of
`
`I
`
`19
`
`15589572 - GAU: 1671
`
`Complete if Known
`Application Number
`Filing Date
`First Named Inventor
`Art Unit
`Examiner Name
`Attorney Docket Number AKBM-14409/US-14/CON
`
`Inge Bruheim
`
`Change(s) applied
`to documen
`t
`/C.C.5/
`10/5/2017
`
`EP 1542670
`
`EP 1631280
`
`FOREIG-N PATENT DOCUMENTS
`2005-06-22
`SUNTORY LIMITED
`
`2004-04-08
`
`BTG INTERNATIONAL
`LIMITED
`
`NIPPON SUISAN KAISHA,
`LTD.
`
`ENZYMOTEC LTD
`
`BRUZZESE
`
`NIPPON SUISAN KAISHA,
`LTD.
`
`BAI KOFF
`
`PICKER NORDSTAR INC.
`
`SUNTORY LTD
`
`CHLORINE ENG CORP LTD
`
`Westfalia Separator
`Industry GmbH
`
`Kohyo
`
`TAIYO FISHERY CO LTD
`
`TAIYO FISHERY CO LTD
`
`TAIYO FISHERY CO LTD
`
`CHLORINE ENG CORP LTD
`
`CHLORINE ENG CORP LTD
`
`IKEDA SHOKKEN KK
`
`NIPPON OIL & FATS CO LTD
`
`GREEN CROSS CORP
`
`CHLORINE ENG CORP LTD
`
`CHLORINE ENG CORP LTD
`
`MATSUSHITA ELECTRIC IND
`CO LTD
`
`Honen Seiyu Co. Ltd. Et al.
`
`SHISEIDO CO LTD; NIPPON
`SUISAN KAISHA LTD.
`
`Kanagawa Kagaku
`Kenkyuujo Co., Ltd. Et al.
`
`EP 1660071
`
`2007-01-17
`
`EP 1689413
`
`EP 1706106
`
`EP 1743531
`
`GB 2097014
`
`GB 921537
`
`JP 02049091
`
`JP 04057853
`
`J p 2003-530448
`
`JP 2004-534800
`
`JP 2215351
`
`JP 2524217
`
`JP 2909508
`
`JP 2963152
`
`JP 3081692
`
`JP 3344887
`
`JP 3467794
`
`JP 3486778
`
`JP 3611222
`
`JP 3678317
`
`JP 4012665
`
`2006-08-16
`
`2009-07-15
`
`2007-01-17
`
`1982-10-27
`
`1999-06-09
`
`1990-02-19
`
`1992-02-25
`
`2003-10-14
`
`2004-11-18
`
`1990-08-28
`
`1996-08-14
`
`1999-06-23
`
`1992-02-25
`
`1994-07-19
`
`1997-07-08
`
`2003-09-05
`
`2003-10-31
`
`1997-08-05
`
`2005-05-20
`
`1992-01-17
`
`JP 60-153779
`
`1985-08-13
`
`JP 61281159
`
`1986-12-11
`
`JP H08-231391
`
`09/1996
`
`Date
`Examiner
`/YATE' K CUTLIFF/
`06/13/2017
`Considered
`Signature
`EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`citation if not in conformance and not considered. Include copy of this form with next communication to applicant.
`RIMFROST EXHIBIT 1113 Page 0002
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`/Y.K.C/
`
`
`
`Doc Code: IFEE
`
`PTOU85B-EFS
`
`Document Description: Issue Fee Payment (PT0-85B)
`
`Application Number
`
`Filing Date
`
`First Named Inventor
`
`Atty. Docket No.
`
`Confirmation No.
`
`Issue Fee Transmittal Form
`
`15589572
`
`08-May-2017
`
`Inge Bruheim
`
`AKBM-14409/US-14/CON
`
`6984
`
`TITLE OF INVENTION :
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`Entity Status
`
`Application Type
`
`Art Unit
`
`Class - Subclass
`
`EXAMINER
`
`Regular Undiscounted
`
`Utility under 35 USC 111 (a)
`
`1671
`
`210000
`
`YATE CUTLIFF
`
`Issue Fee Due
`
`Publication Due
`
`Total Fee(s) Due
`
`Date Due
`
`Prev. Paid Fee
`
`$960
`
`$0
`
`$960
`
`28-Dec-2017
`
`$0
`
`1.Change of Correspondence Address and/or Indication Of Fee Address (37 CFR 1.33 & 1.363)
`Current Correspondence Address:
`Current Indicated Fee Address:
`
`72960
`Casimir Jones, S.C.
`
`2275 DEMING WAY, SUITE 310
`
`MIDDLETON WI 53562
`UNITED STATES
`608-662-1277
`
`D Change of correspondence address requested, system
`generated AIA/122-EFS form attached
`
`D Fee Address indication requested, system generated SB/47-EFS
`form attached
`
`2.Entity Status
`
`Change in Entity Status
`
`0
`
`0
`
`Applicant certifying micro entity status; system generated Micro Entity certification form attached. See 37 CFR 1.29.
`Note: Absent a valid certification of micro entity status, issue fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`If this box is checked, you will be prompted to choose a micro entity status on the gross income basis (37 CFR 1.29(a)) or the institution of higher education basis
`(37 CFR 1.29(d)), and make the applicable certification online.
`
`Applicant asserting small entity status. See 37 CFR 1.27.
`Note: If the application was previously under micro entity status, checking this box will be taken to be a notification of loss of entitlement to micro entity status.
`
`Applicant changing to regular undiscounted fee status.
`Note: Checking this box will be taken to be a notification of loss of entitlement to small or micro entity status, as applicable.
`
`WEB IFEE 1.0
`
`RIMFROST EXHIBIT 1113 Page 0003
`
`
`
`Doc Code: IFEE
`
`PTOU85B-EFS
`
`Document Description: Issue Fee Payment (PT0-85B)
`
`3.The Following Fee(s) Are Submitted:
`
`IZJ
`
`Issue Fee
`
`D Publication Fee
`
`D Advance Order - #of copies
`
`4.Firm and/or Attorney Names To Be Printed
`NOTE: If no name is listed, no name will be printed
`For printing on the patent front page, list to be displayed as entered
`
`1. CASIMIR JONES S.C.
`
`2.
`
`3.
`
`D
`
`I authorize USPTO to apply my previously paid issue fee to the
`current fees due
`
`D
`
`The Director is hereby authorized to apply my previously paid
`issue fee to the current fee due and to charge deficient fees to
`Deposit Account Number
`
`D
`
`If in addition to the payment of the issue fee amount submitted
`with this form, there are any discrepancies in any amount(s) due,
`the Director is authorized to charge any deficiency, or credit any
`overpayment, to Deposit Account Number _______ _
`The issue fee must be submitted with this form. If payment of
`the issue fee does not accompany this form, checking this box
`and providing a deposit account number will NOT be
`effective to satisfy full payment of the fee(s) due.
`
`S.Assignee Name(s) and Residence Data To Be Printed
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent. If an assignee is identified below, the document has been filed for
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`
`Name
`
`City
`
`State
`
`Country
`
`Category
`
`AKER BIOMARINE ANTARCTIC AS
`
`Stamsund
`
`norway
`
`corporation
`
`6.Signature
`
`I certify, in accordance with 37 CFR 1.4(d)(4) that I am an attorney or agent registered to practice before the Patent and Trademark Office who has filed and has been granted
`power of attorney in this application. I also certify that this Fee(s) Transmittal form is being transmitted to the US PTO via EFS-WEB on the date indicated below.
`
`Signature
`
`/J. Mitchell Jones/
`
`Date
`
`09-29-2017
`
`Name
`
`John Mitchell Jones
`
`Registration Number 44174
`
`WEB IFEE 1.0
`
`RIMFROST EXHIBIT 1113 Page 0004
`
`
`
`Electronic Patent Application Fee Transmittal
`
`Application Number:
`
`Filing Date:
`
`15589572
`
`08-May-2017
`
`Title of Invention:
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`First Named Inventor/Applicant Name:
`
`Inge Bruheim
`
`Filer:
`
`John Mitchell Jones/Mallory Checkett
`
`Attorney Docket Number:
`
`AKBM-14409/US-14/CON
`
`Filed as Large Entity
`
`Filing Fees for Utility under 35 USC 111 (a)
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USO($)
`
`Basic Filing:
`
`UTILITY APPL ISSUE FEE
`
`PUBL. FEE- EARLY, VOLUNTARY, OR NORMAL
`
`1501
`
`1504
`
`1
`
`1
`
`960
`
`0
`
`960
`
`0
`
`Pages:
`
`Claims:
`
`Miscellaneous-Filing:
`
`Petition:
`
`Patent-Appeals-and-Interference:
`
`RIMFROST EXHIBIT 1113 Page 0005
`
`
`
`Description
`
`Fee Code
`
`Quantity
`
`Amount
`
`Sub-Total in
`USO($)
`
`Post-Allowance-and-Post-Issuance:
`
`Extension-of-Time:
`
`Miscellaneous:
`
`Total in USO($)
`
`960
`
`RIMFROST EXHIBIT 1113 Page 0006
`
`
`
`Electronic Acknowledgement Receipt
`
`EFSID:
`
`Application Number:
`
`30514890
`
`15589572
`
`International Application Number:
`
`Confirmation Number:
`
`6984
`
`Title of Invention:
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`First Named Inventor/Applicant Name:
`
`Inge Bruheim
`
`Customer Number:
`
`72960
`
`Filer:
`
`John Mitchell Jones/Mallory Checkett
`
`Filer Authorized By:
`
`John Mitchell Jones
`
`Attorney Docket Number:
`
`AKBM-14409/US-14/CON
`
`Receipt Date:
`
`Filing Date:
`
`Time Stamp:
`
`29-SEP-2017
`
`08-MA Y-2017
`
`12:18:58
`
`Application Type:
`
`Utility under 35 USC 111 (a)
`
`Payment information:
`
`Submitted with Payment
`
`Payment Type
`
`Payment was successfully received in RAM
`
`yes
`
`CARD
`
`$960
`
`RAM confirmation Number
`
`1002171NTEFSW12185700
`
`Deposit Account
`
`Authorized User
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`RIMFROST EXHIBIT 1113 Page 0007
`
`
`
`File Listing:
`
`Document
`Number
`
`Document Description
`
`File Name
`
`File Size(Bytes}/
`Message Digest
`
`Multi
`Part /.zip
`
`Pages
`(if appl.)
`
`45897
`
`1
`
`Issue Fee Payment (PT0-85B)
`
`Web85b.pdf
`
`no
`
`2
`
`Warnings:
`
`Information:
`
`17cb9Sb391 d78881f1 c9d6ff01 dfeea523cc
`1739
`
`32042
`
`2
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`no
`
`2
`
`c263 2ada3 7a8a56d 1ff6abe1 SfS 8f33f7 5025
`718
`
`Warnings:
`
`Information:
`
`Total Files Size (in bytes)
`
`77939
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Agglications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date of the application.
`National Stage of an International Agglication under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT /DO/E0/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Agglication Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 181 O), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/R0/1 OS) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`RIMFROST EXHIBIT 1113 Page 0008
`
`
`
`UNITED STA IBS p A IBNT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`72960
`7590
`Casimir Jones, S.C.
`2275 DEMING WAY, SUITE 310
`MIDDLETON, WI 53562
`
`09/28/2017
`
`EXAMINER
`
`CUTLIFF, YA TE KAI RENE
`
`ART UNIT
`
`PAPER NUMBER
`
`1671
`
`DATE MAILED: 09/28/2017
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`15/589,572
`
`05/08/2017
`
`Inge Bruheim
`
`AKBM-14409/US-14/CON
`
`6984
`
`TITLE OF INVENTION: BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATEDUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`12/28/2017
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED. THIS
`STATUTORY PERIOD CANNOT BE EXTENDED. SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`IF AN ISSUE FEE HAS
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`I. Review the ENTITY STATUS shown above. If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies.
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above.
`If the ENTITY STATUS is changed from that shown above, on PART B - FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)".
`For purposes of this notice, small entity fees are 1/2 the amount of undiscounted fees, and micro entity fees are 1/2 the amount of small entity
`fees.
`
`IL PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B.
`
`III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary.
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`PTOL-85 (Rev. 02/11)
`
`Page 1of3
`
`RIMFROST EXHIBIT 1113 Page 0009
`
`
`
`PART B - FEE(S) TRANSMITTAL
`
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`(571)-273-2885
`
`or Fax
`
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1 through 5 should be completed where
`appropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change of address)
`
`72960
`7590
`Casimir Jones, S.C.
`2275 DEMING WAY, SUITE 310
`MIDDLETON, WI 53562
`
`09/28/2017
`
`Note: A certificate of mailing can only be used for domestic mailings of the
`Fee(s) Transmittal. This certificate cannot be used for any other accompanying
`papers. Each additional paper, such as an assignment or formal drawing, must
`have its own certificate of mailing or transmission.
`
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 273-2885, on the date indicated below.
`
`(Depositor's name)
`
`(Signature)
`
`(Date)
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`15/589,572
`
`05/08/2017
`
`Inge Bruheim
`
`AKBM-14409/US-14/CON
`
`6984
`
`TITLE OF INVENTION: BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATEDUE
`
`nonprovisional
`
`UNDISCOUNTED
`
`$960
`
`$0
`
`$0
`
`$960
`
`12/28/2017
`
`EXAMINER
`
`ART UNIT
`
`CLASS-SUBCLASS
`
`CUTLIFF, YATE KAI RENE
`
`1671
`
`554-210000
`
`1. Change of correspondence address or indication of "Fee Address" (37
`CFR 1.363).
`0 Change of correspondence address (or Change of Correspondence
`Address form PTO/SB/122) attached.
`0 "Fee Address" indication (or "Fee Address" Indication form
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`Number is required.
`
`2. For printing on the patent front page, list
`( 1) The names of up to 3 registered patent attorneys
`or agents OR, alternatively,
`(2) The name of a single firm (having as a member a
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`listed, no name will be printed.
`
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent. If an assignee is identified below, the document has been filed for
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) : 0 Individual 0 Corporation or other private group entity 0 Government
`
`4a. The following fee(s) are submitted:
`0 Issue Fee
`0 Publication Fee (No small entity discount permitted)
`0 Advance Order - #of Copies _________ _
`
`4b. Payment ofFee(s): (Please first reapply any previously paid issue fee shown above)
`0 A check is enclosed.
`0 Payment by credit card. Form PT0-2038 is attached.
`0 The director is hereby authorized to charge the required fee( s ), any deficiency, or credits any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`
`5. Change in Entity Status (from status indicated above)
`0 Applicant certifying micro entity status. See 37 CFR 1.29
`0 Applicant asserting small entity status. See 37 CFR 1.27
`0 Applicant changing to regular undiscounted fee status.
`
`NOTE: Absent a valid certification of Micro Entity Status (see forms PTO/SB/15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`NOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`NOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`
`NOTE: This form must be signed in accordance with 37 CFR 1.31and1.33. See 37 CFR 1.4 for signature requirements and certifications.
`
`Authorized Signature _______________________ _
`
`Date ____________________ _
`
`Typed or printed name ______________________ _
`
`Registration No. ________________ _
`
`PTOL-85 Part B (10-13) Approved for use through 10/31/2013.
`
`OMB 0651-0033
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`Page 2 of3
`
`RIMFROST EXHIBIT 1113 Page 0010
`
`
`
`UNITED STA IBS p A IBNT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`15/589,572
`
`05/08/2017
`
`Inge Bruheim
`
`AKBM-14409/US-14/CON
`
`6984
`
`72960
`7590
`Casimir Jones, S,C,
`2275 DEMING WAY, SUITE 310
`MIDDLETON, WI 53562
`
`09/28/2017
`
`EXAMINER
`
`CUTLIFF, YA TE KAI RENE
`
`ART UNIT
`
`PAPER NUMBER
`
`1671
`
`DATE MAILED: 09/28/2017
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(Applications filed on or after May 29, 2000)
`
`The Office has discontinued providing a Patent Term Adjustment (PTA) calculation with the Notice of Allowance.
`
`Section l(h)(2) of the AIA Technical Corrections Act amended 35 U.S.C. 154(b)(3)(B)(i) to eliminate the
`requirement that the Office provide a patent term adjustment determination with the notice of allowance. See
`Revisions to Patent Term Adjustment, 78 Fed. Reg. 19416, 19417 (Apr. 1, 2013). Therefore, the Office is no longer
`providing an initial patent term adjustment determination with the notice of allowance. The Office will continue to
`provide a patent term adjustment determination with the Issue Notification Letter that is mailed to applicant
`approximately three weeks prior to the issue date of the patent, and will include the patent term adjustment on the
`patent. Any request for reconsideration of the patent term adjustment determination (or reinstatement of patent term
`adjustment) should follow the process outlined in 37 CPR 1.705.
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1-(888)-786-0101 or (571 )-272-4200.
`
`PTOL-85 (Rev. 02/11)
`
`Page 3 of 3
`
`RIMFROST EXHIBIT 1113 Page 0011
`
`
`
`OMB Clearance and PRA Burden Statement for PTOL-85 Part B
`
`The Paperwork Reduction Act (PRA) of 1995 requires Federal agencies to obtain Office of Management and
`Budget approval before requesting most types of information from the public. When OMB approves an agency
`request to collect information from the public, OMB (i) provides a valid OMB Control Number and expiration
`date for the agency to display on the instrument that will be used to collect the information and (ii) requires the
`agency to inform the public about the OMB Control Number's legal significance in accordance with 5 CFR
`1320.5(b).
`
`The information collected by PTOL-85 Part B is required by 37 CFR 1.311. The information is required to obtain
`or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete,
`including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary
`depending upon the individual case. Any comments on the amount of time you require to complete this form
`and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, Virginia 22313-1450. DO NOT
`SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box
`1450, Alexandria, Virginia 22313-1450. Under the Paperwork Reduction Act of 1995, no persons are required to
`respond to a collection of information unless it displays a valid OMB control number.
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingly, pursuant to the
`requirements of the Act, please be advised that: (1) the general authority for the collection of this information is
`35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which
`the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission
`related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may result in termination of
`proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of
`Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records
`may be disclosed to the Department of Justice to determine whether disclosure of these records is required
`by the Freedom of Information Act.
`2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence
`to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of
`settlement negotiations.
`3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance
`from the Member with respect to the subject matter of the record.
`4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having
`need for the information in order to perform a contract. Recipients of information shall be required to
`comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of
`records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property
`Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes
`of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C.
`218(c)).
`7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency's
`responsibility to recommend improvements in records management practices and programs, under authority
`of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations
`governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive.
`Such disclosure shall not be used to make determinations about individuals.
`8. A record from this system of records may be disclosed, as a routine use, to the public after either publication
`of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a
`record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the
`record was filed in an application which became abandoned or in which the proceedings were terminated
`and which application is referenced by either a published application, an application open to public
`inspection or an issued patent.
`9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`RIMFROST EXHIBIT 1113 Page 0012
`
`
`
`Notice of Allowability
`
`Application No.
`15/589,572
`Examiner
`YATE' K. CUTLIFF
`
`Applicant(s)
`BRUHEIM ET AL.
`AIA (First Inventor to File)
`Art Unit
`Status
`1671
`No
`
`-- The MAILING DA TE of this communication appears on the cover sheet with the correspondence address-(cid:173)
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application. If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOWABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. [8] This communication is responsive to 812412017.
`DA declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on ___ .
`2. D An election was made by the applicant in response to a restriction requirement set forth during the interview on __ ; the restriction
`requirement and election have been incorporated into this action.
`
`3. [8] The allowed claim(s) is/are 1. 2 & 4 - 20. As a result of the allowed claim(s), you may be eligible to benefit from the Patent
`Prosecution Highway program at a participating intellectual property office for the corresponding application. For more information,
`please see http://www.uspto.gov/patents/init_events/pph/index.jsp or send an inquiry to PPHfeedback@uspto.gov.
`4. D Acknowledgment is made of a claim for foreign priority under 35 U.S.C. ยง 119(a)-(d) or (f).
`Certified copies:
`*c) D None of the:
`a) D All
`b) D Some
`1. D Certified copies of the priority documents have been received.
`2. D Certified copies of the priority documents have been received in Application No. __ .
`3. D Copies of the certified copies of the priority documents have been received in this national stage application from the
`International Bureau (PCT Rule 17.2(a)).
`* Certified copies not received: __ .
`
`Applicant has THREE MONTHS FROM THE "MAILING DATE" of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`5. D CORRECTED DRAWINGS (as "replacement sheets") must be submitted.
`D including changes required by the attached Examiner's Amendment I Comment or in the Office action of
`Paper No./Mail Date __ .
`Identifying indicia such as the application number {see 37 CFR 1.84{c)) should be written on the drawings in the front {not the back) of
`each sheet. Replacement sheet{s) should be labeled as such in the header according to 37 CFR 1.121{d).
`6. 0 DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner's comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. D Notice of References Cited (PT0-892)
`2. [8] Information Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date 8/11 /2017
`3. D Examiner's Comment Regarding Requirement for Deposit
`of Biological Material
`4. [8] Interview Summary (PT0-413),
`Paper No./Mail Date 912512017.
`
`/YATE' K. CUTLIFF/
`Primary Examiner, Art Unit 1671
`
`5. [8] Examiner's Amendment/Comment
`6. [8] Examiner's Statement of Reasons for Allowance
`7. D Other __ .
`
`U.S. Patent and Trademark Office
`PTOL-37 (Rev. 08-13)
`20170925
`
`Notice of Allowability
`
`Part of Paper No./Mail Date
`
`RIMFROST EXHIBIT 1113 Page 0013
`
`
`
`Application/Control Number: 15/589,572
`Art Unit: 1671
`
`Page 2
`
`DETAILED ACTION
`
`Notice of Pre-A/A or AJA Status
`
`1.
`
`The present applic